Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
12.64
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
58
59
Next >
Investors Should Not Lose Faith in Novavax
March 16, 2022
The valuation of NVAX stock is quite attractive while Novavax continues to make progress in many important areas.
Via
InvestorPlace
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
The WHO Foundation CEO, Anil Soni, has told CNBC that the global economy will lose “trillions of dollars” if more COVID-19 vaccines aren&
Via
Benzinga
Check Out What Whales Are Doing With NVAX
March 15, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 14 strange trades.
Via
Benzinga
Best Biotech Stocks To Buy In 2022
March 15, 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...
Via
Talk Markets
Hopes For A Peace Accord
March 14, 2022
The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant.
Via
Talk Markets
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
Is Now The Time To Buy Stock In Novavax, Zoom Or Workhorse?
February 25, 2022
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...
Via
Benzinga
Why Is Novavax (NVAX) Stock in the Spotlight Today?
March 14, 2022
Novavax is once again in the spotlight as China reports near-record numbers of Covid cases. What's going on with NVAX stock?
Via
InvestorPlace
NASDAQ:NVAX Long Term Investor Notice: Investigation of Potential Wrongdoing at Novavax, Inc.
March 14, 2022
San Diego, CA -- (SBWIRE) -- 03/14/2022 -- Certain directors of Novavax, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
50 Stocks Moving In Monday's Mid-Day Session
March 14, 2022
Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,...
Via
Benzinga
Here's Why Pfizer And Novavax Shares Are Rising On Monday
March 14, 2022
Pfizer Inc. (NYSE:PFE) and Novavax, Inc.
Via
Benzinga
Chart Wars: Between Moderna And Novavax, Which COVID Stock Will Soar Higher?
March 09, 2022
Moderna, Inc (NASDAQ: MRNA) and Novavax, Inc (NASDAQ: NVAX) were trading up over 10% and 8%, respectively, at one point on Wednesday, boosted by the S&P 500’s...
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much
March 09, 2022
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 10.65% on an annualized basis. Buying $100 In NVAX: 5 years ago, an investor could have purchased 3.47...
Via
Benzinga
Novavax's COVID-19 Shot Inches Up To FDA Authorization: WSJ
March 07, 2022
Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine is moving toward U.S. authorization after the Company said it resolved manufacturing problems that had held up its...
Via
Benzinga
Novavax Revenue Guidance Does Little to Change Neutral Stance on the Stock
March 04, 2022
NVAX stock's revenue guidance may have given investors a reason to stay invested. However, risks continue to outweigh benefits.
Via
InvestorPlace
10 Biggest Price Target Changes For Thursday
March 03, 2022
Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading.
Via
Benzinga
Russia’s Aggression Could Put a Damper on Novavax Global Vax Deployment
March 02, 2022
The best chance for profits with NVAX stock is with the international market. But Russia's invasion of Ukraine could put Novavax's strategy at risk.
Via
InvestorPlace
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...
Via
Benzinga
What's Going On With Novavax Shares Today?
March 01, 2022
Novavax Inc (NASDAQ: NVAX) is trading higher Tuesday after the company reported fourth-quarter financial results and issued guidance expecting a surge in revenue. Novavax reported...
Via
Benzinga
Novavax Expects At Least $4 Billion In Covid Vaccine Sales This Year; Shares Pop
March 01, 2022
The company missed fourth-quarter expectations, however.
Via
Investor's Business Daily
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6...
Via
Benzinga
My Top Things To Expect This Week
February 28, 2022
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for.
Via
InvestorPlace
Novavax: Q4 Earnings Insights
February 28, 2022
Novavax (NASDAQ:NVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Novavax...
Via
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...
Via
Benzinga
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
February 25, 2022
Moderna has to focus on the rest of its pipeline to keep MRNA stock relevant and profitable as Covid vaccine revenues taper off by 2023.
Via
InvestorPlace
Novavax: The Frustration Is Real, And So Is the Sales Potential
February 25, 2022
All isn't well with NVAX stock, but it is very close to rallying. The results could give Novavax a boost and push the stock high.
Via
InvestorPlace
Novavax Is a Buy on Recent Developments and Cheap Valuation
February 24, 2022
NVAX stock is one of the major players in the vaccine market, which is one that is expected to grow substantially over the next few years.
Via
InvestorPlace
4 Pharma Stocks to Buy Even if the Pandemic Ends
February 24, 2022
Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Production Updates Could Give Novavax Stock a Big Boost
February 22, 2022
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits.
Via
InvestorPlace
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.